Our Team

Carlin Long, MD
Carlin S Long, MD, is a UCSF Professor of Medicine in the Cardiology Division and the Director of the Center for Prevention of Heart and Vascular Disease.

He is the former Chief of Cardiology at Denver Health Medical Center and Director of Research at the University of Colorado Cardiovascular Institute. His research is focused on understanding the role of pro-inflammatory molecules in the transition from compensated to decompensated myocardial failure.

Dr. Long earned his BS in Biology at Baylor University in 1978 and his MD at the University of Texas Southwestern Medical School, where he graduated as an Alpha Omega Alpha scholar in 1982. Dr. Long then received his Internal Medicine training at the University of California San Francisco and served as chief medical resident here from 1985 to 1986.

One of Dr. Long's key areas of research interest is in the role of inflammation in the development and maintenance of cardiac and vascular dysfunction. His focus relates to examining how cells in the heart “speak” to one another in normal and abnormal growth with a particular interest on the “non” muscle cell(s) which initiate the process of scarring within the heart muscle both in response to garden variety injuries such as heart attacks, but also seen in long-standing high blood pressure and some valvular diseases.  

He is also active in the study of various cutting–edge approaches in the arena of replacement/regeneration biology of cardiac repair, utilizing nanotechnology.

Dr. Long is the author or co-author of over 70 publications and is supported by a number of grants from the National Institutes of Health and the American Heart Association. He is a member of the Research Committee for the American Heart Association, Pacific Mountain Affiliate and the Research Committee for the Heart Failure Society of America. He has been elected to the Omicron Delta Kappa, Phi Beta Kappa, and Alpha Omega Alpha societies and he was the recipient of the Outstanding Investigator Award from the Western Society for Clinical Investigation in 2000, among others.